Login / Signup

A phase II study of ibrutinib and short-course fludarabine in previously untreated patients with chronic lymphocytic leukemia.

Christopher PleyerXin TianShakuntala RampertaapRui MuSusan SotoJeanine SuperataErika M GaglioneClare SunJennifer LotterMaryalice Stetler-StevensonConstance M YuanIrina MaricStefania PittalugaSergio RosenzweigThomas FleisherAdrian WiestnerInhye E Ahn
Published in: American journal of hematology (2020)
Keyphrases
  • chronic lymphocytic leukemia
  • phase ii study
  • open label
  • locally advanced
  • placebo controlled
  • squamous cell carcinoma
  • rectal cancer
  • radiation therapy
  • study protocol
  • double blind